Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study
Karim Fizazi(Université Paris-Sud), Michael A. Carducci, Matthew R. Smith(Massachusetts General Hospital), Ronaldo Damião(Hospital Universitário Pedro Ernesto), Janet E. Brown(Cancer Research UK), Lawrence I. Karsh(The Urology Center of Colorado), Piotr Milecki(Greater Poland Cancer Center), Neal D. Shore(Carolina Urologic Research Center), Michael Rader(Nyack Hospital), Huei Wang(Amgen (United States)), Qi Jiang(Amgen (United States)), Sylvia Tadros(Amgen (United States)), Roger Dansey(Amgen (United States)), Carsten Goessl(Amgen (United States))
Cited by 1,958Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis